Oncolytics Biotech (ONCY) Posts Q1 Loss of 6c/Share

Oncolytics Biotech (NASDAQ: ONCY) reported Q1 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Morgan Stanley lifts server market TAM to $809B, boosts targets on compute stocks
• Nike names former Pfizer CFO David Denton as new finance chief